Table 1 The relationship between MTUS1 mRNA expression profiles and clinicopathological parameters using data from 643 CRC patients retrieved from the TCGA database
From: MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer
Characteristic | levels | Overall |
|---|---|---|
n | Â | 644 |
Age | <=65 | 276 (42.9%) |
>65 | 368 (57.1%) | |
Gender | Female | 301 (46.7%) |
Male | 343 (53.3%) | |
T stage | T1 | 20 (3.1%) |
T2 | 111 (17.3%) | |
T3 | 436 (68%) | |
T4 | 74 (11.5%) | |
N stage | N0 | 368 (57.5%) |
N1 | 153 (23.9%) | |
N2 | 119 (18.6%) | |
M stage | M0 | 475 (84.2%) |
M1 | 89 (15.8%) | |
Pathologic stage | Stage I | 111 (17.8%) |
Stage II | 238 (38.2%) | |
Stage III | 184 (29.5%) | |
Stage IV | 90 (14.4%) | |
CEA level | <=5 | 261 (62.9%) |
>5 | 154 (37.1%) | |
Neoplasm type | Colon adenocarcinoma | 478 (74.2%) |
Rectum adenocarcinoma | 166 (25.8%) | |
OS event | Alive | 515 (80%) |
Dead | 129 (20%) |